Lino pharmaceutical package: Net profit in the first quarter of 2026 was 41.0025 million yuan, a year-on-year increase of 1.18%.

Lingno Medicine announced that its revenue in the first quarter of 2026 was 320 million yuan, a year-on-year increase of 15.97%. Net profit was 41.0025 million yuan, a year-on-year increase of 1.18%.